Atezolizumab Plus CArboplatin Plus Nab-paclitaxel
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Triple Negative Breast Cancer|PD-L1 Gene Mutation
Interventions: COMBINATION_PRODUCT: Atezolizumab,Paclitaxel, Carboplatin
Sponsor: Consorzio Oncotech